Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Structures and Soft Tissue Infections”

13 trials

Showing 13 of 13 results

Testing effectiveness (Phase 2)Study completedNCT00633152
What this trial is testing

Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections

Who this might be right for
Bacterial Infection
Forest Laboratories 150
Not applicableStudy completedNCT01293435
What this trial is testing

Study Evaluating Management of Patients With Community-Acquired Pneumonia (CAP) or Complicated Skin Infections

Who this might be right for
Community Acquired Pneumonia (CAP)Complicated Skin and Skin Structures Infections (cSSSI)
AstraZeneca 4,035
Post-approval studies (Phase 4)Ended earlyNCT00102947
What this trial is testing

Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections

Who this might be right for
Soft Tissue Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 72
Testing effectiveness (Phase 2)Study completedNCT00426933
What this trial is testing

Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections

Who this might be right for
Soft Tissue Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 100
Post-approval studies (Phase 4)Study completedNCT00087490
What this trial is testing

Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)

Who this might be right for
Skin/Soft Tissue InfectionsMethicillin Resistant Staphylococcus Aureus (MRSA)
Pfizer 1,077
Large-scale testing (Phase 3)Study completedNCT02877927
What this trial is testing

Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI

Who this might be right for
Bacterial InfectionsSkin Structures and Soft Tissue Infections
Paratek Pharmaceuticals Inc 735
Large-scale testing (Phase 3)Study completedNCT02600611
What this trial is testing

Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1

Who this might be right for
Skin Structures and Soft Tissue Infections
Motif Bio 600
Large-scale testing (Phase 3)Study completedNCT02378480
What this trial is testing

Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)

Who this might be right for
Bacterial InfectionsSkin Structures and Soft Tissue Infections
Paratek Pharmaceuticals Inc 655
Testing effectiveness (Phase 2)Study completedNCT00303589
What this trial is testing

Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Who this might be right for
Soft Tissue Infections
Hoffmann-La Roche 313
Not applicableStudy completedNCT02863874
What this trial is testing

The PLUS Study: Comparison of VicrylPlus® Versus Vicryl® for Repair of Perineal Tears

Who this might be right for
Skin Structures and Soft Tissue InfectionsWound Infection
Region Skane 1,890
Large-scale testing (Phase 3)Study completedNCT01984684
What this trial is testing

Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Who this might be right for
Skin and Subcutaneous Tissue Bacterial InfectionsSkin Structures and Soft Tissue Infections
Melinta Therapeutics, Inc. 850
Large-scale testing (Phase 3)WithdrawnNCT00876850
What this trial is testing

Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

Who this might be right for
Skin Structures and Soft Tissue Infections
Paratek Pharmaceuticals Inc
Large-scale testing (Phase 3)Study completedNCT02607618
What this trial is testing

Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2

Who this might be right for
Skin Structures and Soft Tissue Infections
Motif Bio 613

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation